These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19099217)

  • 21. [Indications critically evaluated: hormone-domain hot flashes].
    MMW Fortschr Med; 2003 Nov; 145(46):5-8. PubMed ID: 14699822
    [No Abstract]   [Full Text] [Related]  

  • 22. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term use of hormone therapy for urogenital complaints: is there a role?
    Hendrix SL
    Med Clin North Am; 2003 Sep; 87(5):1029-37. PubMed ID: 14621329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifestyle risk management--a qualitative analysis of women's descriptions of taking hormone therapy following surgically induced menopause.
    Crowe M; Burrell B; Whitehead L
    J Adv Nurs; 2012 Aug; 68(8):1814-23. PubMed ID: 22082259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone therapy and breast cancer: the press-release version of WHI study data.
    Pines A
    Climacteric; 2013 Apr; 16(2):222-5. PubMed ID: 23488525
    [No Abstract]   [Full Text] [Related]  

  • 27. Turbulent times for hormone replacement therapy: is there a way out?
    Verhaeghe J
    Gynecol Obstet Invest; 2003; 56(1):43-50. PubMed ID: 12876424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reassurance for many healthy women considering HRT.
    Shufelt C; Bairey Merz CN
    BMJ; 2017 Oct; 359():j4652. PubMed ID: 29030494
    [No Abstract]   [Full Text] [Related]  

  • 29. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 30. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States).
    Green PK; Weiss NS; McKnight B; Voigt LF; Beresford SA
    Cancer Causes Control; 1996 Nov; 7(6):575-80. PubMed ID: 8932917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS.
    Harman SM
    Gend Med; 2006 Dec; 3(4):254-69. PubMed ID: 17582367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical?
    Shapiro S
    Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904
    [No Abstract]   [Full Text] [Related]  

  • 37. [HRT in 2006].
    Skalba P
    Endokrynol Pol; 2005; 56(6):952-5. PubMed ID: 16821217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(5):359-364. PubMed ID: 28339370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HRT, HERS, NIH, WHI: alphabet soup?
    Legato MJ
    J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.